BEDFORD, Mass., June 25, 2012 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that they are now providing direct sales, service, support and marketing to end-user customers in the US and Canada, for their Hemostasis product line. A multi-faceted team of sales and technical sales representatives, field service engineers and respective managers has been deployed throughout North America, reinforced by in-house customer and technical support teams. IL's Hemostasis products include the highly successful HemosIL® line of reagents, ACL TOP® Family of Hemostasis Testing Systems, ACL ELITE®/ELITE PRO analyzers and other ACL® systems. The Company's Strategic Alliance Cross-Distribution agreement with Beckman Coulter (BCI) ended on June 22, 2012, after more than twenty successful years.
No stranger to the direct business model, IL has been working directly with customers of their Critical Care product line in North America, for over fifty years. Closer proximity to their Hemostasis customers will allow the Company to quickly respond to changing needs, continuously improve the quality of their products and services, and expedite innovation to Hemostasis labs. Furthermore, Research & Development and Manufacturing for all of IL's Hemostasis analyzers and reagents, along with their world-class Hemostasis expertise, has always resided at their American headquarters, located in Massachusetts and New York, reinforcing their knowledge of the North American market and respective customer needs.
"Applying a direct model for our Hemostasis product line in North America is a very natural and positive step for IL. With the number one market share position in Hemostasis worldwide, expertise and resources, and a solid team in the field, we have everything needed to ensure success," said Ramon Benet, CEO at IL. "Our exclusive corporate focus on Hemostasis and Critical Care diagnostics has always enabled us to not only deliver innovative and quality products, but also to develop close, consultative relationships in the field with our customers. We look forward to doing so with our Hemostasis customers in the US and Canada."
The comprehensive team of field professionals is organized in 9 areas across the United States and Canada, dedicated to Sales, Service and Support. Introductions and visitations to Hemostasis customer sites were initiated today. Augmenting the field effort, IL Customer Service is available at 1-800-678-0710, option 2, or at ILresponse@ilww.com to address any questions.
"For the past several weeks, I have been meeting with customers across North America and presenting our direct business plans for Hemostasis. The response has been very positive," said Brian Durkin, Vice President, Commercial Operations, North America at IL. "Customers have complete confidence in our ability to provide them with the highest level of support. Knowing the group of exceptionally skilled and experienced professionals we have onboard, I can say without hesitation, that we will not only meet, but exceed, our customers' expectations."
IL will honor all customer contracts, including end-user and Group Purchasing Organization agreements. All current pricing, terms and conditions will remain in effect through the term of any existing agreement.
Today, IL is the number one manufacturer of instruments and reagents for the Hemostasis market worldwide. Since the introduction of the first fully automated Hemostasis analyzer, the ACL® 810 in 1985, IL has continuously introduced innovative instruments and reagents to hospital and specialty labs, culminating in the release of the ACL TOP Family of Hemostasis Testing Systems. This line of fully automated analyzers is the leading Hemostasis product line in the world. The Company has strong, established relationships with key scientific and industry leaders in Hemostasis, and has always been the source of technical, scientific and field service expertise.
About Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include Critical Care systems, Hemostasis systems and information management systems. IL's GEM® product offerings, part of the Critical Care line, include the GEM Premier™ 4000 analyzer with Intelligent Quality Management (iQM®), GEM Premier 3500, GEMweb® Plus Custom Connectivity, and the GEM PCL Plus, a portable coagulation analyzer. IL's Hemostasis portfolio includes the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP 700, ACL TOP 700 LAS, ACL TOP 700 CTS, and ACL TOP 500 CTS. IL also offers the ACL ELITE®, other Hemostasis analyzers and the HemosIL® line of reagents. IL is part of the Werfen Group, a privately held company based in Barcelona, Spain. IL is headquartered in Bedford, Massachusetts.
The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.
SOURCE Instrumentation Laboratory